Sivanesan Dakshanamurthy

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 26

Top Topics

Molecular Docking

Machine Learning

Top Venues

International journal of molecular sciences

Diseases (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Saptarshi Roy, James Moran, Keerthana Danasekaran, Kate O'Brien, Sivanesan Dakshanamurthy
Large-Scale Screening of Per- and Polyfluoroalkyl Substance Binding Interactions and Their Mixtures with Nuclear Receptors. International journal of molecular sciences 25 (15) (2024)
Enrico Bautista, Young Hyun Jung, Manuela Jaramillo, Harrish Ganesh, Aryaan Varma, Kush Savsani, Sivanesan Dakshanamurthy
AutoPepVax, a Novel Machine-Learning-Based Program for Vaccine Design: Application to a Pan-Cancer Vaccine Targeting EGFR Missense Mutations. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Sarita Limbu, Eric Glasgow, Tessa Block, Sivanesan Dakshanamurthy
A Machine-Learning-Driven Pathophysiology-Based New Approach Method for the Dose-Dependent Assessment of Hazardous Chemical Mixtures and Experimental Validations. Toxics 12 (7) (2024)
Kush Savsani, Sivanesan Dakshanamurthy
Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma. Diseases (Basel, Switzerland) 12 (7) (2024)
Sarita Limbu, Eric Glasgow, Tessa Block, Sivanesan Dakshanamurthy
A Machine-Learning-Driven Pathophysiology-Based New Approach Method for the Dose-Dependent Assessment of Hazardous Chemical Mixtures and Experimental Validations. Toxics 12 (7) (2024)
Madhav Samudrala, Sindhusri Dhaveji, Kush Savsani, Sivanesan Dakshanamurthy
AutoEpiCollect, a Novel Machine Learning-Based GUI Software for Vaccine Design: Application to Pan-Cancer Vaccine Design Targeting PIK3CA Neoantigens. Bioengineering (Basel, Switzerland) 11 (4) (2024)
Sarita Limbu, Eric Glasgow, Tessa Block, Sivanesan Dakshanamurthy
A Machine-Learning-Driven Pathophysiology-Based New Approach Method for the Dose-Dependent Assessment of Hazardous Chemical Mixtures and Experimental Validations. Toxics 12 (7) (2024)
Kush Savsani, Sivanesan Dakshanamurthy
Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma. Diseases (Basel, Switzerland) 12 (7) (2024)
Saptarshi Roy, James Moran, Keerthana Danasekaran, Kate O'Brien, Sivanesan Dakshanamurthy
Large-Scale Screening of Per- and Polyfluoroalkyl Substance Binding Interactions and Their Mixtures with Nuclear Receptors. International journal of molecular sciences 25 (15) (2024)
Kush Savsani, Sivanesan Dakshanamurthy
Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma. Diseases (Basel, Switzerland) 12 (7) (2024)
Madhav Samudrala, Sindhusri Dhaveji, Kush Savsani, Sivanesan Dakshanamurthy
AutoEpiCollect, a Novel Machine Learning-Based GUI Software for Vaccine Design: Application to Pan-Cancer Vaccine Design Targeting PIK3CA Neoantigens. Bioengineering (Basel, Switzerland) 11 (4) (2024)
Enrico Bautista, Young Hyun Jung, Manuela Jaramillo, Harrish Ganesh, Aryaan Varma, Kush Savsani, Sivanesan Dakshanamurthy
AutoPepVax, a Novel Machine-Learning-Based Program for Vaccine Design: Application to a Pan-Cancer Vaccine Targeting EGFR Missense Mutations. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Sarita Limbu, Sivanesan Dakshanamurthy
Predicting Dose-Dependent Carcinogenicity of Chemical Mixtures Using a Novel Hybrid Neural Network Framework and Mathematical Approach. Toxics 11 (7) (2023)
Minji Kim, Kush Savsani, Sivanesan Dakshanamurthy
A Peptide Vaccine Design Targeting KIT Mutations in Acute Myeloid Leukemia. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Sarita Limbu, Sivanesan Dakshanamurthy
A New Hybrid Neural Network Deep Learning Method for Protein-Ligand Binding Affinity Prediction and De Novo Drug Design. International journal of molecular sciences 23 (22) (2022)
Naiem T Issa, Stephen W Byers, Sivanesan Dakshanamurthy
ES-Screen: A Novel Electrostatics-Driven Method for Drug Discovery Virtual Screening. International journal of molecular sciences 23 (23) (2022)
Sarita Limbu, Sivanesan Dakshanamurthy
Predicting Chemical Carcinogens Using a Hybrid Neural Network Deep Learning Method. Sensors (Basel, Switzerland) 22 (21) (2022)
Naiem T Issa, Stephen W Byers, Sivanesan Dakshanamurthy
ES-Screen: A Novel Electrostatics-Driven Method for Drug Discovery Virtual Screening. International journal of molecular sciences 23 (23) (2022)
Naiem T Issa, Stephen W Byers, Sivanesan Dakshanamurthy
ES-Screen: A Novel Electrostatics-Driven Method for Drug Discovery Virtual Screening. International journal of molecular sciences 23 (23) (2022)
Sidharth Jain, Samantha Rego, Steven Park, Yiran Liu, Simone Parn, Kush Savsani, David S Perlin, Sivanesan Dakshanamurthy
RNASeq profiling of COVID19-infected patients identified an EIF2AK2 inhibitor as a potent SARS-CoV-2 antiviral. Clinical and translational medicine 12 (11) (2022)
Sarita Limbu, Cyril Zakka, Sivanesan Dakshanamurthy
Predicting Dose-Range Chemical Toxicity using Novel Hybrid Deep Machine-Learning Method. Toxics 10 (11) (2022)
Sadhana Suri, Sivanesan Dakshanamurthy
IntegralVac: A Machine Learning-Based Comprehensive Multivalent Epitope Vaccine Design Method. Vaccines 10 (10) (2022)
Naiem T Issa, Stephen W Byers, Sivanesan Dakshanamurthy
ES-Screen: A Novel Electrostatics-Driven Method for Drug Discovery Virtual Screening. International journal of molecular sciences 23 (23) (2022)
Martha D Gay, Hong Cao, Narayan Shivapurkar, Sivanesan Dakshanamurthy, Bhaskar Kallakury, Robin D Tucker, John Kwagyan, Nicholas Osborne
Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome. International journal of molecular sciences 23 (3) (2022)
Kush Savsani, Gabriel Jabbour, Sivanesan Dakshanamurthy
A New Epitope Selection Method: Application to Design a Multi-Valent Epitope Vaccine Targeting HRAS Oncogene in Squamous Cell Carcinoma. Vaccines 10 (1) (2021)
Shifaa O Alshammari, Sivanesan Dakshanamurthy, Hemayet Ullah
Small compounds targeting tyrosine phosphorylation of Scaffold Protein Receptor for Activated C Kinase1A (RACK1A) regulate auxin mediated lateral root development in Arabidopsis. Plant signaling & behavior 16 (5) (2021)